A detailed history of Carderock Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Carderock Capital Management Inc holds 8,971 shares of LLY stock, worth $7.14 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
8,971
Previous 7,765 15.53%
Holding current value
$7.14 Million
Previous $7.03 Million 13.04%
% of portfolio
1.95%
Previous 1.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $931,200 - $1.16 Million
1,206 Added 15.53%
8,971 $7.95 Million
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $5.63 Million - $7.06 Million
7,765 New
7,765 $7.03 Million
Q1 2023

Apr 19, 2023

BUY
$310.63 - $364.82 $57,466 - $67,491
185 New
185 $63,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Carderock Capital Management Inc Portfolio

Follow Carderock Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carderock Capital Management Inc with notifications on news.